A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma.
Kefford RF, Thomas NP, Corrie PG, Palmer C, Abdi E, Kotasek D, Beith J, Ranson M, Mortimer P, Watson AJ, Margison GP, Middleton MR.
Kefford RF, et al. Among authors: middleton mr.
Br J Cancer. 2009 Apr 21;100(8):1245-9. doi: 10.1038/sj.bjc.6605016. Epub 2009 Mar 31.
Br J Cancer. 2009.
PMID: 19367282
Free PMC article.
Clinical Trial.